UPDATE: Clovis Oncology (CLVS) Misses Q1 EPS by 4c (Correction)

(Updated - May 6, 2015 3:57 PM EDT)

Clovis Oncology (NASDAQ: CLVS) reported Q1 EPS of ($1.86), $0.04 worse than the analyst estimate of ($1.82). Revenue for the quarter came in at $0 , versus $13.6 million reported last year.

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c
• Eos Energy Enterprises (EOSE) PT Lowered to $5 at B.Riley